헌팅턴병 치료 시장 규모는 향후 몇 년 동안 빠르게 성장하여 2029년에는 13억 5,000만 달러에 달할 것으로 예상되며, 연평균 13.0%의 성장률을 보일 것으로 예측됩니다. 이 예측 기간의 성장은 개인 맞춤형 의료에 대한 관심 증가, 디지털 건강 모니터링의 통합 발전, 희귀질환 치료제에 대한 규제 당국의 지원 강화, 증상 치료 치료제에 대한 수요 증가, 질병 조절 치료제에 대한 수요 증가에 의해 주도될 것으로 예측됩니다. 이 기간의 주요 동향으로는 기술 주도형 유전자 침묵 도구의 발전, 세포 기반 치료법 개발, 말초 바이오마커의 출현, 헌팅턴병 치료에 대한 원격 의료의 통합, 환자 보고 결과의 활용, 질병 조절 약물의 지속적인 혁신 등이 있습니다.
헌팅턴병 치료 시장의 성장을 견인할 것으로 예상되는 것은 유전적 원인을 표적으로 삼아 질병의 진행을 늦추는 유전자 치료의 이용 확대입니다. 유전자 치료는 유전자 수준에서 질병을 치료하거나 예방하기 위해 결함이 있는 유전자를 바꾸거나 대체하는 치료법입니다. 정밀의료가 계속 발전하고 있는 가운데, 유전자 치료는 근본적인 유전적 원인을 직접 표적으로 삼을 수 있는 능력을 제공함으로써 기존 치료 대비 치료 결과를 개선할 수 있습니다. 헌팅턴병의 경우, 유전자 치료는 유해 단백질을 생성하는 결함이 있는 HTT 유전자를 침묵시켜 신경세포의 손상을 방지하는 것을 목표로 합니다. 이 접근법은 질병의 진행을 늦추고, 뇌 기능을 보호하며, 장기적으로 질병을 통제할 수 있는 가능성을 제공합니다. 예를 들어, 2023년 7월 미국 유전자 및 세포치료학회(ASGCT)와 씨트라인(Citeline)은 2023년 2분기 말까지 임상 2상 시험 중인 유전자 치료제의 수가 247개에서 260개로 5% 증가했다고 보고했습니다. 이처럼 유전자 치료제 증가가 시장 성장에 기여하고 있습니다.
헌팅턴병 치료 시장은 선택적 소낭 모노아민 수송체 2(VMAT2) 억제제 캡슐과 같이 환자의 삶의 질을 향상시키면서 질병의 진행을 늦추는 것을 목표로 하는 개발에도 집중하고 있습니다. 에 관여하는 단백질을 억제함으로써 작용합니다. 이 약물들은 신경전달물질의 방출을 억제하여 불수의적 운동 및 기타 관련 증상을 조절하는 데 도움이 됩니다. 예를 들어, 뉴로크라인 바이오사이언스는 2023년 8월 성인 헌팅턴병에 수반되는 무도병 치료제로 1일 1회 경구용 VMAT2 억제제인 인그레자(성분명: 바베나딘) 캡슐을 FDA로부터 승인받았습니다. 본 제제는 뇌 내 과도한 도파민 신호전달을 억제하여 불수의적 운동을 억제하는 약물로, 다양한 강도의 캡슐이 구비되어 있어 환자의 편의에 따라 복용방법을 선택할 수 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나재난과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계 헌팅턴병 치료 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
- 최종 이용 산업 분석
- 세계의 헌팅턴병 치료 시장 : 성장률 분석
- 세계의 헌팅턴병 치료 시장 실적 : 규모와 성장, 2019-2024년
- 세계의 헌팅턴병 치료 시장 예측 : 규모와 성장, 2024-2029년, 2034년
- 세계 헌팅턴병 치료 전체 시장(TAM)
제6장 시장 세분화
- 세계의 헌팅턴병 치료 시장 : 시술별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
- 치료
- 질환 조절 요법
- 세계의 헌팅턴병 치료 시장 : 투여 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
- 경구
- 정맥내
- 피하
- 국소
- 세계의 헌팅턴병 치료 시장 : 치료별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
- 유전성 질환
- 신경 질환
- 정신 질환
- 세계의 헌팅턴병 치료 시장 : 유통 채널별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
- 병원 약국
- 소매 약국
- 온라인 약국
- 세계의 헌팅턴병 치료 시장 : 최종사용자별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
- 병원
- 클리닉
- 가정치료 환경
- 연구센터
- 세계의 헌팅턴병 치료 시장 : 대처 요법, 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
- 항우울제
- 항정신병제
- 기분 안정제
- 무도병 치료제
- 인지 기능 향상제
- 세계의 헌팅턴병 치료 시장 : 질환 조절 요법 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
- 유전자 치료
- 신경 보호제
- RNA 기반 치료법
- 줄기세포 요법
- 단백질 표적치료
제7장 지역별/국가별 분석
- 세계의 헌팅턴병 치료 시장 : 지역별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
- 세계의 헌팅턴병 치료 시장 : 국가별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
- 헌팅턴병 치료 시장 : 경쟁 구도
- 헌팅턴병 치료 시장 : 기업 개요
- F. Hoffmann-La Roche Ltd. : 개요, 제품 및 서비스, 전략 및 재무 분석
- Novartis AG : 개요, 제품 및 서비스, 전략 및 재무 분석
- Teva Pharmaceutical Industries Ltd. : 개요, 제품 및 서비스, 전략 및 재무 분석
- Vertex Pharmaceuticals Incorporated : 개요, 제품 및 서비스, 전략 및 재무 분석
- Bausch Health Companies Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
- Sun Pharmaceutical Industries Inc.
- H. Lundbeck A/S
- WaVe Life Sciences Ltd.
- Dr. Reddy's Laboratories Ltd.
- Hikma Pharmaceuticals plc
- Lupin Limited
- Neurocrine Biosciences Inc.
- Alnylam Pharmaceuticals Inc.
- PTC Therapeutics Inc.
- Ionis Pharmaceuticals Inc.
- Annexon Inc.
- Uniqure NV
- Sage Therapeutics Inc.
- Azevan Pharmaceuticals Inc.
- Prilenia Therapeutics B.V.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
- 헌팅턴병 치료 시장, 2029년 : 새로운 기회를 제공하는 국가
- 헌팅턴병 치료 시장, 2029년 : 새로운 기회를 제공하는 부문
- 헌팅턴병 치료 시장, 2029년 : 성장 전략
제36장 부록
LSH
Huntington's disease treatment consists of medical therapies aimed at managing the symptoms of this progressive neurological condition. The main objective is to slow the disease's progression, reduce symptoms, and improve the patient's quality of life.
The primary types of treatment for Huntington's disease are symptomatic treatments and disease-modifying therapies. Symptomatic treatments focus on alleviating the symptoms of Huntington's disease and enhancing quality of life, without targeting the underlying cause. These treatments are becoming increasingly sought after as patients look for better ways to manage daily challenges. Various methods are used to administer these treatments, including oral, intravenous, subcutaneous, and topical routes, for applications in genetic, neurological, and psychiatric disorders. These treatments are available through multiple distribution channels, such as hospital pharmacies, retail pharmacies, and online pharmacies, and are used by a wide range of end users, including hospitals, clinics, home care settings, and research institutions.
The Huntington's disease treatment market research report is one of a series of new reports from The Business Research Company that provides Huntington's disease treatment market statistics, including the Huntington's disease treatment industry's global market size, regional shares, competitors with the Huntington's disease treatment market share, detailed Huntington's disease treatment market segments, market trends and opportunities, and any further data you may need to thrive in the Huntington's disease treatment market. This Huntington's disease treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The Huntington's disease treatment market size has grown rapidly in recent years. It will grow from $0.73 billion in 2024 to $0.83 billion in 2025 at a compound annual growth rate (CAGR) of 13.3%. The growth observed in the historical period can be attributed to several factors, including increased awareness of genetic disorders, improved accessibility to genetic testing, higher investment in neurodegenerative disease research, a rise in the number of clinical trials for experimental therapies, and a growing pipeline of disease-modifying drugs.
The Huntington's disease treatment market size is expected to see rapid growth in the next few years. It will grow to $1.35 billion in 2029 at a compound annual growth rate (CAGR) of 13.0%. The growth in the forecast period is expected to be driven by a stronger focus on personalized medicine, greater integration of digital health monitoring, increased regulatory support for orphan drugs, rising demand for therapies that provide symptomatic relief, and a higher demand for disease-modifying treatments. Key trends during this period are likely to include advancements in technology-driven gene silencing tools, the development of cell-based therapies, the emergence of peripheral biomarkers, the integration of telehealth into Huntington's disease care, the incorporation of patient-reported outcomes, and continued innovation in disease-modifying drugs.
The growth of the Huntington's disease treatment market is expected to be driven by the increasing use of gene therapies, which target genetic causes and slow disease progression. Gene therapies are treatments that alter or replace defective genes to cure or prevent diseases at the genetic level. As precision medicine continues to advance, gene therapies offer the ability to directly target the underlying genetic causes, leading to improved outcomes compared to traditional treatments. In Huntington's disease, gene therapies aim to silence the defective HTT gene that produces harmful proteins, thus preventing nerve cell damage. This approach helps slow disease progression, protect brain function, and provides potential for long-term control. For example, in July 2023, the American Society of Gene & Cell Therapy (ASGCT) and Citeline reported that the number of gene therapies in phase II clinical trials increased by 5% from 247 to 260 by the end of Q2 2023. As such, the increase in gene therapies is contributing to the market's growth.
Companies in the Huntington's disease treatment market are also focusing on the development of advanced therapies, such as selective vesicular monoamine transporter 2 (VMAT2) inhibitor capsules, which aim to improve patient quality of life while slowing disease progression. VMAT2 inhibitors work by blocking a protein involved in packaging neurotransmitters for release in the brain. These drugs reduce neurotransmitter release, helping manage involuntary movements and other related symptoms. For example, in August 2023, Neurocrine Biosciences received FDA approval for Ingrezza (valbenazine) capsules, a once-daily oral VMAT2 inhibitor for the treatment of chorea associated with Huntington's disease in adults. This medication helps control involuntary movements by reducing excessive dopamine signaling in the brain and is available in various strengths, offering a convenient dosing option for patients.
In December 2024, PTC Therapeutics, a US-based pharmaceutical company developing treatments for Huntington's disease, entered into a partnership with Novartis AG to advance the development of PTC518, a potential first-in-class oral, disease-modifying therapy for Huntington's disease. This collaboration aims to accelerate the development and global commercialization of PTC518. Novartis AG, a Switzerland-based pharmaceutical company, specializes in drugs for Huntington's disease.
Major players in the huntington's disease treatment market are F. Hoffmann-La Roche Ltd., Novartis AG, Teva Pharmaceutical Industries Ltd., Vertex Pharmaceuticals Incorporated, Bausch Health Companies Inc., Sun Pharmaceutical Industries Inc., H. Lundbeck A/S, WaVe Life Sciences Ltd., Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals plc, Lupin Limited, Neurocrine Biosciences Inc., Alnylam Pharmaceuticals Inc., PTC Therapeutics Inc., Ionis Pharmaceuticals Inc., Annexon Inc., Uniqure NV, Sage Therapeutics Inc., Azevan Pharmaceuticals Inc., Prilenia Therapeutics B.V.
North America was the largest region in the Huntington's disease treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in Huntington's disease treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the Huntington's disease treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The Huntington's disease treatment market consists of sales of products including tetrabenazine, deutetrabenazine, huntingtin-lowering therapies, cannabinoids, and cognitive enhancers. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods
The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Huntington's Disease Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on huntington's disease treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for huntington's disease treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The huntington's disease treatment market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Treatment: Symptomatic Treatment; Disease-Modifying Therapies
- 2) By Administration Type: Oral; Intravenous; Subcutaneous; Topical
- 3) By Therapeutic: Genetic Disorders; Neurological Disorders; Psychiatric Disorders
- 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
- 5) By End-User: Hospitals; Clinics; Homecare Settings; Research Centers
Subsegments
- 1) By Symptomatic Treatment: Antidepressants; Antipsychotics; Mood Stabilizers; Chorea Medications; Cognitive Enhancers
- 2) By Disease-Modifying Therapies: Gene Therapy; Neuroprotective Agents; RNA-Based Therapies; Stem Cell Therapy; Protein-Targeting Therapies
- Companies Mentioned: F. Hoffmann-La Roche Ltd.; Novartis AG; Teva Pharmaceutical Industries Ltd.; Vertex Pharmaceuticals Incorporated; Bausch Health Companies Inc.
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Huntington's Disease Treatment Market Characteristics
3. Huntington's Disease Treatment Market Trends And Strategies
4. Huntington's Disease Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Huntington's Disease Treatment Growth Analysis And Strategic Analysis Framework
- 5.1. Global Huntington's Disease Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Huntington's Disease Treatment Market Growth Rate Analysis
- 5.4. Global Huntington's Disease Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Huntington's Disease Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Huntington's Disease Treatment Total Addressable Market (TAM)
6. Huntington's Disease Treatment Market Segmentation
- 6.1. Global Huntington's Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Symptomatic Treatment
- Disease-Modifying Therapies
- 6.2. Global Huntington's Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Oral
- Intravenous
- Subcutaneous
- Topical
- 6.3. Global Huntington's Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Genetic Disorders
- Neurological Disorders
- Psychiatric Disorders
- 6.4. Global Huntington's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- 6.5. Global Huntington's Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals
- Clinics
- Homecare Settings
- Research Centers
- 6.6. Global Huntington's Disease Treatment Market, Sub-Segmentation Of Symptomatic Treatment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Antidepressants
- Antipsychotics
- Mood Stabilizers
- Chorea Medications
- Cognitive Enhancers
- 6.7. Global Huntington's Disease Treatment Market, Sub-Segmentation Of Disease-Modifying Therapies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Gene Therapy
- Neuroprotective Agents
- RNA-Based Therapies
- Stem Cell Therapy
- Protein-Targeting Therapies
7. Huntington's Disease Treatment Market Regional And Country Analysis
- 7.1. Global Huntington's Disease Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Huntington's Disease Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Huntington's Disease Treatment Market
- 8.1. Asia-Pacific Huntington's Disease Treatment Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Huntington's Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Huntington's Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Huntington's Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Huntington's Disease Treatment Market
- 9.1. China Huntington's Disease Treatment Market Overview
- 9.2. China Huntington's Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Huntington's Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Huntington's Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Huntington's Disease Treatment Market
- 10.1. India Huntington's Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Huntington's Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Huntington's Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Huntington's Disease Treatment Market
- 11.1. Japan Huntington's Disease Treatment Market Overview
- 11.2. Japan Huntington's Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Huntington's Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Huntington's Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Huntington's Disease Treatment Market
- 12.1. Australia Huntington's Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Huntington's Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Huntington's Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Huntington's Disease Treatment Market
- 13.1. Indonesia Huntington's Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Huntington's Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Huntington's Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Huntington's Disease Treatment Market
- 14.1. South Korea Huntington's Disease Treatment Market Overview
- 14.2. South Korea Huntington's Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Huntington's Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Huntington's Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Huntington's Disease Treatment Market
- 15.1. Western Europe Huntington's Disease Treatment Market Overview
- 15.2. Western Europe Huntington's Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Huntington's Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Huntington's Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Huntington's Disease Treatment Market
- 16.1. UK Huntington's Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Huntington's Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Huntington's Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Huntington's Disease Treatment Market
- 17.1. Germany Huntington's Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Huntington's Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Huntington's Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Huntington's Disease Treatment Market
- 18.1. France Huntington's Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Huntington's Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Huntington's Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Huntington's Disease Treatment Market
- 19.1. Italy Huntington's Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Huntington's Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Huntington's Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Huntington's Disease Treatment Market
- 20.1. Spain Huntington's Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Huntington's Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Huntington's Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Huntington's Disease Treatment Market
- 21.1. Eastern Europe Huntington's Disease Treatment Market Overview
- 21.2. Eastern Europe Huntington's Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Huntington's Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Huntington's Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Huntington's Disease Treatment Market
- 22.1. Russia Huntington's Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Huntington's Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Huntington's Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Huntington's Disease Treatment Market
- 23.1. North America Huntington's Disease Treatment Market Overview
- 23.2. North America Huntington's Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Huntington's Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Huntington's Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Huntington's Disease Treatment Market
- 24.1. USA Huntington's Disease Treatment Market Overview
- 24.2. USA Huntington's Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Huntington's Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Huntington's Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Huntington's Disease Treatment Market
- 25.1. Canada Huntington's Disease Treatment Market Overview
- 25.2. Canada Huntington's Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Huntington's Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Huntington's Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Huntington's Disease Treatment Market
- 26.1. South America Huntington's Disease Treatment Market Overview
- 26.2. South America Huntington's Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Huntington's Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Huntington's Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Huntington's Disease Treatment Market
- 27.1. Brazil Huntington's Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Huntington's Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Huntington's Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Huntington's Disease Treatment Market
- 28.1. Middle East Huntington's Disease Treatment Market Overview
- 28.2. Middle East Huntington's Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Huntington's Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Huntington's Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Huntington's Disease Treatment Market
- 29.1. Africa Huntington's Disease Treatment Market Overview
- 29.2. Africa Huntington's Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Huntington's Disease Treatment Market, Segmentation By Administration Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Huntington's Disease Treatment Market, Segmentation By Therapeutic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Huntington's Disease Treatment Market Competitive Landscape And Company Profiles
- 30.1. Huntington's Disease Treatment Market Competitive Landscape
- 30.2. Huntington's Disease Treatment Market Company Profiles
- 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Vertex Pharmaceuticals Incorporated Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Bausch Health Companies Inc. Overview, Products and Services, Strategy and Financial Analysis
31. Huntington's Disease Treatment Market Other Major And Innovative Companies
- 31.1. Sun Pharmaceutical Industries Inc.
- 31.2. H. Lundbeck A/S
- 31.3. WaVe Life Sciences Ltd.
- 31.4. Dr. Reddy's Laboratories Ltd.
- 31.5. Hikma Pharmaceuticals plc
- 31.6. Lupin Limited
- 31.7. Neurocrine Biosciences Inc.
- 31.8. Alnylam Pharmaceuticals Inc.
- 31.9. PTC Therapeutics Inc.
- 31.10. Ionis Pharmaceuticals Inc.
- 31.11. Annexon Inc.
- 31.12. Uniqure NV
- 31.13. Sage Therapeutics Inc.
- 31.14. Azevan Pharmaceuticals Inc.
- 31.15. Prilenia Therapeutics B.V.
32. Global Huntington's Disease Treatment Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Huntington's Disease Treatment Market
34. Recent Developments In The Huntington's Disease Treatment Market
35. Huntington's Disease Treatment Market High Potential Countries, Segments and Strategies
- 35.1 Huntington's Disease Treatment Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Huntington's Disease Treatment Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Huntington's Disease Treatment Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
